245 related articles for article (PubMed ID: 20977805)
1. [Statins in COPD--theoretical reflections].
Hannink JD; Heijdra YF
Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
[TBL] [Abstract][Full Text] [Related]
2. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
Young RP; Hopkins R; Eaton TE
Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
[TBL] [Abstract][Full Text] [Related]
3. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
4. [Causes of death and prediction of mortality in COPD].
Solanes Garcia I; Casan Clarà P
Arch Bronconeumol; 2010 Jul; 46(7):343-6. PubMed ID: 20471740
[No Abstract] [Full Text] [Related]
5. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
[TBL] [Abstract][Full Text] [Related]
6. Systemic manifestations and comorbidities of COPD.
Barnes PJ; Celli BR
Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological actions of statins: potential utility in COPD.
Young RP; Hopkins R; Eaton TE
Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
[TBL] [Abstract][Full Text] [Related]
9. Treating systemic effects of COPD.
Cazzola M; Matera MG; Rogliani P; Page C
Trends Pharmacol Sci; 2007 Oct; 28(10):544-50. PubMed ID: 17897727
[TBL] [Abstract][Full Text] [Related]
10. [Chronic obstructive pulmonary disease and cardiovascular system].
Gürgün A; Gürgün C
Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
[TBL] [Abstract][Full Text] [Related]
11. Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.
Young RP; Hopkins RJ
Expert Rev Respir Med; 2013 Oct; 7(5):533-44. PubMed ID: 24138695
[TBL] [Abstract][Full Text] [Related]
12. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
[TBL] [Abstract][Full Text] [Related]
13. [Chronic obstructive pulmonary disease and cardiovascular diseases].
Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
[TBL] [Abstract][Full Text] [Related]
14. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease: a concise review.
Balkissoon R; Lommatzsch S; Carolan B; Make B
Med Clin North Am; 2011 Nov; 95(6):1125-41. PubMed ID: 22032431
[TBL] [Abstract][Full Text] [Related]
16. COPD and cancer mortality: the influence of statins.
van Gestel YR; Hoeks SE; Sin DD; Hüzeir V; Stam H; Mertens FW; van Domburg RT; Bax JJ; Poldermans D
Thorax; 2009 Nov; 64(11):963-7. PubMed ID: 19720607
[TBL] [Abstract][Full Text] [Related]
17. Toward immunomodulatory and anti-inflammatory properties of statins.
Arnaud C; Braunersreuther V; Mach F
Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
Sin DD; Man SF
Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
[TBL] [Abstract][Full Text] [Related]
19. What do the statins tell us?
LaRosa JC
Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
[TBL] [Abstract][Full Text] [Related]
20. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
Howard ML; Vincent AH
Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
